X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - PHARMIWEB.COM - Events listing for this month - 02/Sep 04:49

8th MASH Drug Development Summit

Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim, AstraZeneca, Amgen, Akero Therapeutics and more that hold huge promise in Phase 1, 2, and 3 clinical trials. Paired with the boom of GLP-1s, these milestones have reinvigorated investment throughout the metabolic space. The 8th MASH Drug Development Summit is the perfect forum to unite and discuss the evolving drug development opportunity for MASH an...

Articles similaires

Sorry! Image not available at this time

Healthy.io, Geisinger and Boehringer Ingelheim Reveal Milestone Data at AHA 2024

healthtechzone.com - 10/Sep 13:35

Sorry! Image not available at this time

Healthy.io, Geisinger and Boehringer Ingelheim Reveal Milestone Data at AHA 2024

healthtechzone.com - 10/Sep 13:35

Sorry! Image not available at this time

Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

drugs.com - 05/Sep 05:09

SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

drugs.com - 05/Sep 05:09

SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

healthtechzone.com - 05/Sep 10:30

Sorry! Image not available at this time

Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid

healthtechzone.com - 05/Sep 10:30

Sorry! Image not available at this time

Levodopa-induced Dyskinesia Market Growth Anticipated by 2032 | Companies includes Adamas Pharmaceuticals, Acorda Therapeutics, Impel NeuroPharma, Neurocrine Biosciences, Kyowa Kirin, Sunovion Pharma

mountaintoday.in - 12/Sep 08:52

Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...

Sorry! Image not available at this time

Levodopa-induced Dyskinesia Market Growth Anticipated by 2032 | Companies includes Adamas Pharmaceuticals, Acorda Therapeutics, Impel NeuroPharma, Neurocrine Biosciences, Kyowa Kirin, Sunovion Pharma

mountaintoday.in - 12/Sep 08:52

Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...

Sorry! Image not available at this time

Biolexis Unveils Promising Data with an Oral Weight Loss Drug: BLX-7006 Shows Significant Results in Preclinical Studies

drugs.com - 12/Sep 14:09

LEHI, Utah., Sept. 12, 2024. Biolexis Therapeutics, a biopharmaceutical company pioneering next-generation weight loss treatments, today announced the...

Sorry! Image not available at this time

DHL relocates major facility for biopharmaceutical outfit

primemovermag.com.au - 03/Sep 00:19

DHL Supply Chain CEO, Australia and New Zealand, Steve Thompsett; Boehringer Ingelheim General Manager Australia, Dirk Otto; and Consul General of the...

Les derniers communiqués